new glp-1 Weight Loss Drugs May Reduce Chance of Cancer Progressing, Study Finds 3 Takeaways from the Landmark

It is why the week felt easier or harder than the week before

Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): A randomised trial

These changes are a key reason why fiber intake and digestive support are commonly recommended for people using GLP-1 medications

58 BW was significantly reduced (up to 4.9% placebo-adjusted, p=0.013) over 4 weeks

label similarly describes postmarketing acute kidney injury events often occurring in patients who experienced gastrointestinal reactions leading to dehydration, and recommends monitoring renal function in those with reactions that could lead to volume depletion